US IPO Issuance in September Stalled with Third Quarter Slowest in Decades

Along with the misery of global stock markets in September the IPO market grounded to a halt. The worst third quarter for new issuers in over a decade, with 25 IPOs raising $2.4 billion. There was some relief in the IPO market in August which came to an end with the bear market relief rally. IPO interest is on pace for its worst year in decades. In August, the traditionally slow month with Europe on holidays monthly issuance hit double … Continue reading “US IPO Issuance in September Stalled with Third Quarter Slowest in Decades”

US Weekly IPO and SPAC Monitor: Biotechs Jupiter Neurosciences and Alopexx with Laser Photonics

The IPO issuance slows down in the week ahead after AIG spin Corebridge Financial (CRBG) was the biggest IPO of 2022 thus far.  Three small deals may price in the week ahead, Neuro-inflammation biotech Jupiter Neurosciences (JUNS) is the largest. Two nano-caps may price in the week ahead, infectious disease biotech Alopexx (ALPX) and laser-based system maker Laser Photonics (LASE). Last week six issuers began trading, AIG spin-off Corebridge $CRBG, the largest deal of 2022. Third Harmonic Bio (THRD) upsized, Nexalin Technology (NXL) … Continue reading “US Weekly IPO and SPAC Monitor: Biotechs Jupiter Neurosciences and Alopexx with Laser Photonics”

US Weekly IPO and SPAC Monitor: AIG spin-off Corebridge, Third Harmonic Bio and LINKBANCORP

AIG spin-off Corebridge $CRBG, in what could be the largest deal of 2022 so far, plans to raise $1.8 billion at a fully diluted market value of $14.7 billion-week next week. Six other deals are expected to begin trading in the week ahead including biotech Third Harmonic Bio (THRD), China based Lichen China (LICN), neurostimulation medical device maker Nexalin Technology (NXL) and non-invasive neural input technology company Wearable Devices (WLDS). Two companies are planning to up list from the OTC. Pennsylvania-based The Gratz Bank LINKBANCORP (LNKB) and Bio- … Continue reading “US Weekly IPO and SPAC Monitor: AIG spin-off Corebridge, Third Harmonic Bio and LINKBANCORP”

US Weekly IPO and SPAC Monitor: Bio-RFID AI Company Know Labs and Neural Biotech Wearable Devices

Heading into September IPOs are still small in number, though August delivered the most IPO issues for the year with 12. In a shortened Labor Day week two small deals are scheduled to price. Bio- RFID sensor technology company, OTC-listed Know Labs (KNW) plans to raise $6 million at a $123 million market cap.  A holdover from last week, non-invasive neural input technology company Wearable Devices (WLDS) plans to raise $22 million at a $99 million market cap. Last week we had … Continue reading “US Weekly IPO and SPAC Monitor: Bio-RFID AI Company Know Labs and Neural Biotech Wearable Devices”

US IPO Issuance in August Highest For 2022

With IPO interest on pace for its worst year in decades it came as a surprise that in August, the traditionally slow month with Europe on holidays monthly issuance hit double digits for the first time this year. There were 12 small IPOs issued, raising a combined $196 million. The largest deal raised just $36 million, and the median deal size remained low at $15 million. Renaissance Capital said August IPOs averaged a return of over 1,000% from offer due … Continue reading “US IPO Issuance in August Highest For 2022”

US Weekly IPO and SPAC Monitor: Hemp Cigarette’s Hempacco, Wearable Devices and bioAffinity Technologies

IPO interest is on pace for its worst year in decades after the market crashing the IPO market has been in the doldrums. New companies have few options but to burn through cash while they wait for the stock market to calm. Three small deals are scheduled to price in the week ahead. Hemp cigarette manufacturer Hempacco (HPCO), non-invasive neural input technology company Wearable Devices (WLDS) and Lung cancer diagnostics developer bioAffinity Technologies (BIAF) Last week we had Malaysian fintech … Continue reading “US Weekly IPO and SPAC Monitor: Hemp Cigarette’s Hempacco, Wearable Devices and bioAffinity Technologies”